Medicines Co. (MDCO) News Nov 20, 2014, 5:36

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Medicines Co. (MDCO) News Nov 20, 2014, 5:36 p.m.
MarketWatch News on MDCO
Medicines Co. shares fall after FDA panel rejects drug application 10:54 a.m. Feb. 13, 2014 - Russ Britt
FDA reviewing Medicines Co. anti-clotting drug 7:56 a.m. Feb. 12, 2014 - MarketWatch.com
Three biopharma companies poised for product OKs in 2014: analyst 12:51 p.m. Jan. 6, 2014 - Russ Britt
Sam Eisenstadt still bullish on stocks 3:28 p.m. Dec. 27, 2013 - Mark Hulbert
Why I stopped using stop loss orders 7:31 a.m. May 9, 2013 - Michael Sincere
Dow, Nasdaq challenge multiyear highs 12:43 p.m. Feb. 19, 2013 - Michael Ashbaugh
Dow, Nasdaq rattle cage on multi-year highs 11:31 a.m. Feb. 19, 2013 - Michael Ashbaugh
Updates, advisories and surprises 9:01 p.m. July 25, 2012 - MarketWatch
Medicines Co. shares jump 12% on earnings report 11:17 a.m. July 25, 2012 - Val Brickates Kennedy
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Stocks to watch Wednesday: Prestige, Timken, Dell 6:59 a.m. Feb. 22, 2012 - MarketWatch
Friday's biggest gaining and declining stocks 4:25 p.m. Sept. 10, 2010 - MarketWatch
Medicines Co. says patent extension denied 5:29 p.m. March 19, 2010 - Wallace Witkowski
Medicines Co. shares tumble on patent defeat 2:50 p.m. March 19, 2010 - Val Brickates Kennedy
A.P. Pharma, Medicines Co. sink 11:22 a.m. March 19, 2010 - Val Brickates Kennedy
Medicines Co. shares reverse, down 9.7% to $8.40 11:01 a.m. March 19, 2010 - Wallace Witkowski
Wednesday's biggest gaining and declining stocks 4:08 p.m. March 17, 2010 - MarketWatch
Abraxis soars; Molecular Insight falls 12:14 p.m. March 17, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:27 p.m. Feb. 17, 2010 - MarketWatch
Medicines Co. gets wider EU OK for anticoagulant 4:03 a.m. Dec. 1, 2009 - Robert Daniel


Other News on MDCO
The Medicines Company (MDCO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 20, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA KND MDCO 6:45 a.m. Nov. 20, 2014 - InvestorPlace.com
Expect More Specialty Pharma Deals 7:41 a.m. Nov. 14, 2014 - Barrons.com
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 11:28 a.m. Oct. 29, 2014 - Zacks.com
The Medicines Company (MDCO) Jumps: Stock Gains 16.5% - Tale of the Tape 8:25 a.m. Oct. 29, 2014 - Zacks.com
The Medicines Co.'s Angiomax Gets Favorable Court Ruling - Analyst Blog 5:31 p.m. Oct. 28, 2014 - Zacks.com
Twitter Takes A Tumble As Ability To Innovate Comes Into Question 11:44 a.m. Oct. 28, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – TRNX MDCO ACHN AMGN 6:30 a.m. Oct. 28, 2014 - InvestorPlace.com
The Medicines Co.'s Q3 Earnings Fall Y/Y, Guidance Lowered - Analyst Blog 12:00 p.m. Oct. 27, 2014 - Zacks.com
The Medicines' (MDCO) CEO Clive Meanwell on Q3 2014 Results - Earnings Call Transcript 2:43 p.m. Oct. 22, 2014 - Seeking Alpha
The Medicines (MDCO) Q3 2014 Results - Earnings Call Webcast 7:25 a.m. Oct. 22, 2014 - Seeking Alpha
Actavis Expands Antibiotics Presence With Durata Buy 8:58 a.m. Oct. 6, 2014 - Investors Business Daily
Hottest Healthcare Stocks Now – LCI ANAC HALO IRWD 1:00 p.m. Sept. 10, 2014 - InvestorPlace.com
Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog 4:20 p.m. Aug. 26, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – LGND PODD MDCO CNMD 12:15 p.m. Aug. 26, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AVNR PBYI CMN MYGN 1:00 p.m. Aug. 18, 2014 - InvestorPlace.com
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 2:54 p.m. Aug. 8, 2014 - Zacks.com
The Medicines Co. Offers Investors 25% Upside 9:48 a.m. Aug. 8, 2014 - Barrons.com

Press Releases on MDCO
The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters and Was Well-Tolerated in Healthy and Coronary Artery Disease (CAD) Patients 10:30 a.m. Nov. 16, 2014 - BusinessWire - BZX
The Medicines Company to Present New Data on Investigational Lipid-Modifying Agent MDCO-216and Investigational Antiplatelet Agent Cangrelor at 2014 American Heart Association (AHA) Annual Scientific Sessions in Chicago 10:32 a.m. Nov. 14, 2014 - BusinessWire - BZX
The Medicines Company to Participate in Credit Suisse Healthcare Conference 11:07 a.m. Nov. 11, 2014 - BusinessWire - BZX
Health Economic Data on The Medicines Company’s Infectious Disease and Cardiology Portfolios to be Presented at the 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3:00 p.m. Nov. 7, 2014 - BusinessWire - BZX
The Medicines Company Announces First Patient Enrollment in Phase 3 Studies of CARBAVANCE™ in Development for the Treatment of Serious Bacterial Infections Due to Gram-Negative Bacteria 6:30 a.m. Nov. 5, 2014 - BusinessWire - BZX
Update to The Medicines Company Investor & Analyst Day on November 5 4:33 p.m. Nov. 4, 2014 - BusinessWire - BZX
The Medicines Company to Webcast Investor & Analyst Day onNovember 5 4:07 p.m. Oct. 30, 2014 - BusinessWire - BZX
The Medicines Company Announces Presentation of Investigational Hemostatic Agent RAPLIXA™ (fibrin sealant) Phase III FINISH-3 Trial Results at the 2014 Clinical Conference of the American College of Surgeons 11:30 a.m. Oct. 28, 2014 - BusinessWire - BZX
Alnylam and The Medicines Company Announce Filing of a Clinical Trial Application to Initiate a Phase 1 Study for ALN-PCSsc, an Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia 8:05 a.m. Oct. 28, 2014 - BusinessWire - BZX
The Medicines Company Wins Favorable Judgment in Angiomax® (Bivalirudin) Patent Litigation 8:04 p.m. Oct. 27, 2014 - BusinessWire - BZX
The Medicines Company Announces Participation in 2014 American College of Emergency Physicians Scientific Assembly 2:54 p.m. Oct. 24, 2014 - BusinessWire - BZX
Opposing Market Forces Lead to Limited Growth of the Acute Pain Market Through 2023 2:00 p.m. Oct. 23, 2014 - PR Newswire - PRF
The Medicines Company Reports Third Quarter and First Nine Months 2014 Results 7:03 a.m. Oct. 22, 2014 - BusinessWire - BZX
Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:34 p.m. Oct. 14, 2014 - PR Newswire - PRF
The Medicines Company to Announce Third Quarter 2014 Financial Results on Wednesday, October 22, 2014 7:20 p.m. Oct. 8, 2014 - BusinessWire - BZX
The Medicines Company Infectious Disease Portfolio Data to Be Presented at ID Week 2014 2:22 p.m. Oct. 6, 2014 - BusinessWire - BZX
The Medicines Company to Webcast Infectious Disease Care Investor & Analyst Day on September 24 7:00 p.m. Sept. 23, 2014 - BusinessWire - BZX
Frazier Healthcare Appoints David Socks as Venture Partner, Establishes Boston Presence 8:00 a.m. Sept. 19, 2014 - BusinessWire - BZX
The Medicines Company to Review ORBACTIVTM (oritavancin) Launch Readiness on Tuesday, September 16, 2014 11:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
The Medicines Company to Present New Data from its Infectious Disease Portfolio at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1:12 p.m. Aug. 27, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 42

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 136

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 68

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 80

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 160

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Update for Investors in Metagenomi Class Action

Updated Category News Views 103

Key Deadline for Metagenomi Investors As investors in Metagenomi, Inc. keep a close watch, an important deadline is approaching. The time to file a lead plaintiff motion in the class action lawsuit is set for November 25, 2024. This action is vital for those who purchased or acquired Metagenomi securities, specifically those linked to the company’s latest initial public...

Continue Reading
Structure Therapeutics Engages with Investors at Key Conferences

Updated Category News Views 78

Structure Therapeutics Engages with Investors at Key Conferences Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is gearing up to participate in important investor conferences this September. The company is dedicated to developing innovative oral small molecule therapeutics aimed at treating metabolic and cardiopulmonary...

Continue Reading
OmaSp Reports Solid Financial Performance with Growth Prospects

Updated Category News Views 156

OmaSp's Strong Financial Performance and Future Outlook OMA SAVINGS BANK PLC has recently released its financial statements for the year ending December 31, 2024, showing promising results and projections for continued growth. Known as OmaSp, the bank reported a noteworthy fourth quarter, aligning with the expectations set forth at the beginning of the year, and a solid...

Continue Reading
Unveiling the Reagan National Economic Forum for Future Growth

Updated Category News Views 485

Reagan National Economic Forum Set to Inspire Economic Solutions The Ronald Reagan Presidential Foundation and Institute is gearing up for a transformative inaugural economic summit with leading figures from the business and economic policy landscapes to take place in late May 2025. About the Forum’s Objectives The Reagan National Economic Forum (RNEF) aims to provide a...

Continue Reading
Experience the Vibrant Latin Business Networking Event of 2025

Updated Category News Views 279

Celebrating the Latino Business Community Prepare yourself for an unforgettable networking event dedicated to the Latino business community, brought to you by Latin Biz Today and Mercy University. The Spectrum of Success event promises a night filled with excitement, learning, and cultural experiences that will leave a lasting impression on everyone involved. A Night of...

Continue Reading